On September 2022, crypto millionaire James Altucher published a video saying he had sold all his Bitcoin... and doubled down on this crypto instead. At the time, cryptos had already dropped 70%. But James still said this crypto was a good investment. Was he right? Or did he embarrass himself?
Luke Lango is now recommending this little-known A.I. stock because it could supply Elon Musk with a critical piece of infrastructure for his new A.I. venture, something Luke is calling "Elon's A.I. 2.0". Once Elon reveals it on May 16, you may have missed the biggest gains.
A Big Pharma giant quietly bought one AI-designed drug for $4 billion designed by a tiny AI-biotech company. Wall Street doesn't yet grasp how this company is quietly revolutionizing the drug discovery business but this won't stay quiet much longer.
Luke Lango is now recommending this little-known A.I. stock because it could supply Elon Musk with a critical piece of infrastructure for his new A.I. venture, something Luke is calling "Elon's A.I. 2.0". Once Elon reveals it on May 16, you may have missed the biggest gains.
I urge you to check it out before we take the video down. You'll discover how AI discovered a new treatment in only 30 days, why Big Pharma signed over $3 billion in deals with one AI-biotech, and why Bill Gates and billionaire Steve Cohen own over 10% of this company.
His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.